Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myeloma

Equality Impact Assessment (Guidance development) (PDF 161 KB)

Register of interests (PDF 159 KB)

Final draft guidance

Committee papers (PDF 852 KB)

Public committee slides (PDF 671 KB)

Final appraisal document (PDF 244 KB)

Draft guidance

Appraisal consultation document (PDF version) (PDF 248 KB)

Appraisal consultation document (online commenting)

Committee papers (PDF 4.02 MB)

Public committee slides (PDF 807 KB)

Final stakeholder list (PDF 184 KB)

Draft scope and provisional stakeholder list comments table (post-referral) (PDF 328 KB)

Equality impact assessment (Scoping) (PDF 127 KB)

Final scope (PDF 181 KB)